Evidence map›Paper›PMID 33972596›Full record

ArticleScientific reports2021

Rift Valley fever virus detection in susceptible hosts with special emphasis in insects.

K M Gregor, L M Michaely, B Gutjahr, M Rissmann, M Keller, S Dornbusch, F Naccache, K Schön, S Jansen, A Heitmann and 10 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. An Introduction to Rift Valley Fever Virus.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Dissecting the Species-Specific Virome inFrontiers in microbiology · 2022
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 2 countries.

K M Gregor *Department of Pathology, University of Veterinary Medicine Hannover, Hannover, Germany.
L M Michaely *Department of Pathology, University of Veterinary Medicine Hannover, Hannover, Germany.
B Gutjahr *Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institute, Greifswald, Germany.
M RissmannInstitute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institute, Greifswald, Germany.
M KellerInstitute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institute, Greifswald, Germany.
S DornbuschInstitute for Parasitology and Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Hannover, Germany.
F NaccacheInstitute for Parasitology and Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Hannover, Germany.
K SchönInstitute for Parasitology and Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Hannover, Germany.
S JansenDepartment of Arbovirology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
A HeitmannDepartment of Arbovirology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
R KönigInstitute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institute, Greifswald, Germany.
B BrennanMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, UK.
R M ElliottMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, UK.
S BeckerInstitute for Parasitology and Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Hannover, Germany.
M EidenInstitute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institute, Greifswald, Germany.
I SpitzbarthInstitute of Veterinary Pathology, Faculty of Veterinary Medicine, Leipzig University, Leipzig, Germany.
W BaumgärtnerDepartment of Pathology, University of Veterinary Medicine Hannover, Hannover, Germany. Wolfgang.Baumgaertner@tiho-hannover.de.
C PuffDepartment of Pathology, University of Veterinary Medicine Hannover, Hannover, Germany.
R UlrichInstitute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institute, Greifswald, Germany.
M H GroschupInstitute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institute, Greifswald, Germany.
University of Veterinary Medicine Hannover, Foundation · DEFriedrich-Loeffler-Institut · DEBernhard Nocht Institute for Tropical Medicine · DELeipzig University · DEMRC University of Glasgow Centre for Virus Research · GB

Funding

Medical Research Council MC_UU_12014/8Wellcome Trust 210462/Z/18/Z
6 · The paper itself

Abstract

Rift Valley fever phlebovirus (RVFV, Phenuiviridae) is an emerging arbovirus that can cause potentially fatal disease in many host species including ruminants and humans. Thus, tools to detect this pathogen within tissue samples from routine diagnostic investigations or for research purposes are of major interest. This study compares the immunohistological usefulness of several mono- and polyclonal antibodies against RVFV epitopes in tissue samples derived from natural hosts of epidemiologic importance (sheep), potentially virus transmitting insect species (Culex quinquefasciatus, Aedes aegypti) as well as scientific infection models (mouse, Drosophila melanogaster, C6/36 cell pellet). While the nucleoprotein was the epitope most prominently detected in mammal and mosquito tissue samples, fruit fly tissues showed expression of glycoproteins only. Antibodies against non-structural proteins exhibited single cell reactions in salivary glands of mosquitoes and the C6/36 cell pellet. However, as single antibodies exhibited a cross reactivity of varying degree in non-infected specimens, a careful interpretation of positive reactions and consideration of adequate controls remains of critical importance. The results suggest that primary antibodies directed against viral nucleoproteins and glycoproteins can facilitate RVFV detection in mammals and insects, respectively, and therefore will allow RVFV detection for diagnostic and research purposes.

Indexed as

AedesAnimalsAntibodies, ViralCell LineChlorocebus aethiopsCross ReactionsCulexDisease Models, AnimalDrosophila melanogasterEpitopesFeasibility StudiesFemaleHumansImmunohistochemistryMiceMosquito VectorsAntibodies, ViralEpitopesNucleocapsid ProteinsViral Envelope Proteins

Identifiers

PMID33972596
PMCPMC8110843
OpenAlexW3162518392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.